# Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

> **NCT01841996** · PHASE1 · COMPLETED · sponsor: **Meiji Seika Pharma Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** ME1111 solution
- **DRUG:** Vehicle Solution

## Key facts

- **NCT ID:** NCT01841996
- **Lead sponsor:** Meiji Seika Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841996, "Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01841996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*